These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15981630)

  • 1. [An autopsy case of rapid progressed cholangiolocellular carcinoma].
    Takeuchi S; Sugai N; Seki H; Miura A; Fujita J; Suzuki J; Fukazawa Y
    Nihon Shokakibyo Gakkai Zasshi; 2005 Jun; 102(6):718-22. PubMed ID: 15981630
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma.
    Watanabe M; Akagi S; Hamamoto S
    Am J Gastroenterol; 1999 Aug; 94(8):2320-1. PubMed ID: 10445582
    [No Abstract]   [Full Text] [Related]  

  • 3. [Case 6: Combined hepatocellular and cholangiocarcinoma].
    Bedossa P
    Ann Pathol; 2007 Apr; 27(2):112-4. PubMed ID: 17909467
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combined hepatocellular and cholangiocellular carcinoma: a case report with invasion to the left hepatic duct of hepatocellular carcinoma].
    Ogata T; Ohwada S; Fukusato T; Nakamura S; Kawashima Y; Morishita Y; Matsumoto M; Kon Y
    Nihon Shokakibyo Gakkai Zasshi; 1996 Jun; 93(6):428-32. PubMed ID: 8752762
    [No Abstract]   [Full Text] [Related]  

  • 5. A Ring in the Liver.
    Xu J; Liang X; Cai X
    Am J Gastroenterol; 2021 Jan; 116(1):220-222. PubMed ID: 32868632
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary intrahepatic small-cell carcinoma arising from combined hepatocellular and cholangiocarcinomas.
    Khaw YL; Nolan N; Heaslip I; McCormick PA; Sheahan K
    J Clin Oncol; 2011 Jul; 29(21):e630-3. PubMed ID: 21606429
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.
    Lee JH; Chung GE; Yu SJ; Hwang SY; Kim JS; Kim HY; Yoon JH; Lee HS; Yi NJ; Suh KS; Lee KU; Jang JJ; Kim YJ
    J Clin Gastroenterol; 2011 Jan; 45(1):69-75. PubMed ID: 20142755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepato-cholangiocarcinoma with diffuse metastases and hypercalcemia].
    Pérez Roldán F; Carretero L; Aguirre A; Bañares R; Casado M; Cos E; Clemente G
    Rev Esp Enferm Dig; 1995 Oct; 87(10):743-7. PubMed ID: 8519543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double cancer - hepatocellular carcinoma and intrahepatic cholangiocarcinoma with a spindle-cell variant.
    Itamoto T; Asahara T; Katayama K; Momisako H; Dohi K; Shimamoto F
    J Hepatobiliary Pancreat Surg; 1999; 6(4):422-6. PubMed ID: 10664295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones".
    Hunt JP; Varnholt H
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649
    [No Abstract]   [Full Text] [Related]  

  • 11. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
    Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
    Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
    Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
    Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
    Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
    Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of double liver cancer: hepatocellular carcinoma and combined hepatocellular and mucinous cholangiocarcinoma].
    Yamashita N; Nishiura S; Tanimoto H; Yamamoto H; Nomura H
    Nihon Shokakibyo Gakkai Zasshi; 2013 Sep; 110(9):1663-72. PubMed ID: 24005108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma.
    Kai K; Ide Y; Miyoshi A; Masuda M; Ide T; Kitahara K; Irie H; Nakajima J; Noshiro H; Tokunaga O
    Pathol Int; 2013 Aug; 63(8):419-21. PubMed ID: 23957918
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver.
    Morita D; Kagata Y; Ogata S; Tsuda H; Hatsuse K; Mochizuki H; Matsubara O
    Pathol Int; 2006 Apr; 56(4):222-6. PubMed ID: 16634969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcomatoid combined hepatocellular-cholangiocarcinoma: a case report and review of literature.
    Chin S; Kim Z
    Int J Clin Exp Pathol; 2014; 7(11):8290-4. PubMed ID: 25550887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
    Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
    Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous double cancers of primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a case report and review of the literature.
    Wu C; Bai DS; Jiang GQ; Jin SJ
    World J Surg Oncol; 2014 Nov; 12():337. PubMed ID: 25385169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcomatous cholangiocarcinoma.
    Gupta K; Powari M; Dey P
    Diagn Cytopathol; 2003 Mar; 28(3):168-9. PubMed ID: 12619101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.